Presented
by

Presented by Oxford Global

Discover PLUS Pass

All Immuno Content

Bringing you the latest research in immuno-oncology, autoimmunity, therapeutic modalities and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.

Insight Article
Understanding and Overcoming the Immunosuppressive TME
Explore the intricate world of the immunosuppressive tumor microenvironment (TME), a key player in cancer progression and treatment resistance
Edited by Guillaume Alonso |
08 December 2023
Tumour Microenvironment
Industry Spotlight
Immunostimulatory Oncolytic Viruses: Interview with Angelica Loskog, CEO, Lokon Pharma
Diving deep into Lokon Pharma's immunostimulatory oncolytic virus programme. Learn about their LOAd platform, transition to the clinic, and more.
Edited by Tom Cohen |
14 November 2023
Therapeutic Modalities
Industry Spotlight
Oncolytic Virus Immunotherapy: A Revolutionary Approach in Immuno-Oncology
Explore the cutting-edge of oncolytic virus immunotherapy in immuno-oncology: the viruses revolutionizing cancer treatment and the promise they hold for future therapies.
Edited by Guillaume Alonso |
14 November 2023
Tumour Microenvironment, Immuno Series
Industry Spotlight
The Therapeutic Modulation of Cytokines with Pierre Ferré, VP of Pre-Clinical Development, Compugen
Compugen's candidate therapeutic, COM503, targets interleukin-18 binding protein to unleash interleukin-18's immunostimulatory power.
13 November 2023
Tumour Microenvironment
Industry Spotlight
Positive Phase I Data from Oncolytic Virotherapy Trial
TILT-123, an oncolytic virotherapy, has shown promising results from a phase I clinical trial which treats solid tumours in patients that have exhausted other options.
Edited by Tom Cohen |
07 November 2023
Tumour Microenvironment
Industry Spotlight
Bispecific Antibody Format: Interview with Laura von Schantz, Chief Technology Officer, Alligator Biosciences
Talking with Laura von Schantz, Chief Technology Officer, at Alligator Biosciences about their RUBY bispecific antibody format.
Edited by Tom Cohen |
02 November 2023
Therapeutic Modalities
Whitepaper
Immune Cell-mediated Killing of A549 Cancer Target Cells in Real-time
Nanion Technologies GmbH, Munich. TUM, Munich
01 November 2023
Biomarkers in Immuno-Oncology
Whitepaper
Hyperion XTi™ Imaging System
Uniquely designed for clinical research.
01 November 2023
Biomarkers in Immuno-Oncology
Whitepaper
AtlaZ: Quantitative Live-Cell Analytics
Welcome to the next level of live-cell analytics.
01 November 2023
Biomarkers in Immuno-Oncology
Whitepaper
Nanion: Cell Analytics Brochure
Next level live-cell kinetic and phenotypic assays.
01 November 2023
Biomarkers in Immuno-Oncology

Search by Keyword

Filter by Subject Area

Immuno Series – Subject

Filter by Content Type

Resource Formats (incl. Industry Spotlight)

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.